منابع مشابه
Heptabarbitone as a Pre-operative Sedative.
There are advantages to be gained from using an oral barbiturate as a pre-operative sedative. Heptabarbitone (Medomin) has been given in a dose of 400 mg to fifty healthy patients undergoing minor gynaecological operations. Using a scoring system, the sedative effects of diis drug have been measured and found to be comparable with the sedation produced by papaveretum 20 mg and hyoscine 0.4 mg a...
متن کاملDexmedetomidine hydrochloride as a long-term sedative
Dexmedetomidine undoubtedly is a useful sedative in the intensive care setting because it has a minimal effect on the respiratory system. Dexmedetomidine infusions lasting more than 24 hours have not been approved since the first approval was acquired in the US in 1999. However, in 2008, dexmedetomidine infusions for prolonged use were approved in Colombia and in the Dominican Republic, and the...
متن کاملMidazolam as intravenous sedative for electrocardioversion.
Of the various agents which have been employed for sedation in patients undergoing electrocardioversion, diazepam has had the most extensive use. However, this agent possesses several disadvantages including pain and venous complications at the site of injection and a lower incidence of amnesia. Midazolam, a benzodiazepine derivative, is being increasingly used in general and local anesthesia a...
متن کاملMagnesium as a diagnostic marker of cancer
Magnesium plays a key role in many essential cellular processes. It is recognized that magnesium deficiency may lead to many disorders like cardiovascular disease, diabetes mellitus, hypertension, myocardial infarction or even cancer. Connection between magnesium concentration in body fluids and cancer occurrence still becomes unclear. Magnesium ions are crucial cofactors for enzymes involved D...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Psychiatry
سال: 1922
ISSN: 0002-953X,1535-7228
DOI: 10.1176/ajp.78.4.637